Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers
NCT05522335
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
3160
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19 Respiratory Infection
Interventions
BIOLOGICAL:
BBV154(Intranasal) & covaxin
Sponsor
Bharat Biotech International Limited